Showing 321 results

Filters Content type: News, Editors' picks, About HIV Topic: Drug interactions & pharmacokinetics

Taking two or more different drugs together may result in an alteration in the effectiveness or in the side-effects of one or more of the drugs. Pharmacokinetics (PK) is the study of how a drug is absorbed into the body and distributed in different parts of the body. Pharmacodynamics (PD) is the study of the impact of different concentrations of a drug on the body.

Cancer

Advice on Best ART Regimen for Patients Taking Cancer Therapy

Editor's pick
International AIDS Society
25 June 2014
TB treatment

In HIV/TB coinfection, raltegravir may be an alternative to efavirenz

Editor's pick
Medscape
2 June 2014
New & experimental hepatitis C treatment

No critical interactions between ledipasvirsofosbuvir and certain key antiretrovirals

Editor's pick
NATAP
29 May 2014
Drug interactions & pharmacokinetics

Calcium and Iron Supplements Lower Dolutegravir Levels When Taken Between Meals

Editor's pick
NATAP
24 May 2014
Drug interactions & pharmacokinetics

Better Late Than Never: Efavirenz Dose Optimization

Editor's pick
Treatment Action Group
3 April 2014
TB treatment

Announcement: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

Editor's pick
Morbidity and Mortality Weekly Report
31 March 2014
Nutrition

Malnutrition decreases effectiveness of HIV treatment in pregnant African women

Editor's pick
Eurekalert Medicine & Health
19 February 2014
Drug interactions & pharmacokinetics

High incidence of antiretroviral prescribing errors in Nigeria

News
7 February 2014
Hepatitis C treatment

Victrelis (boceprevir) label changes update contraindications and drug interactions

Editor's pick
FDA
23 January 2014
Drug interactions & pharmacokinetics

Risk of Harmful Drug Interactions Rises With Age in HIV+ US Group

Editor's pick
International AIDS Society
26 November 2013
Drug interactions & pharmacokinetics

Ritonavir the cause of the interaction between telaprevir and ritonavir-boosted atazanavir

News
25 November 2013
Drug interactions & pharmacokinetics

Merck plans phase III study of once-daily raltegravir (Isentress)

Editor's pick
Merck press release
16 October 2013
Improving HIV care

Studies look at community vs hospital-based HIV care and medication issues

News
7 October 2013
New & experimental HIV treatments

European Commission Approves Gilead Sciences' Tybost(TM), a New Boosting Agent for HIV Therapy

Editor's pick
Gilead press release
26 September 2013
Drug interactions & pharmacokinetics

New NNRTI MK-1439 interacts with ritonavir but not tenofovir

News
17 September 2013
New & experimental HIV treatments

New tenofovir formulation works equally well with less effect on kidneys and bones

News
13 September 2013
Cancer

Raltegravir is a good choice for people with HIV undergoing cancer chemotherapy

News
13 September 2013
TB treatment

Adding Blood Pressure Drug to Standard Antibiotics Speeds Up TB Treatment

Editor's pick
Johns Hopkins Medicine press release
2 September 2013
People who inject drugs

High prevalence of heart rhythm disturbance among HIV-positive people on methadone maintenance therapy

News
13 August 2013
Drug interactions & pharmacokinetics

Trials challenging HIV drug doses could usher in huge cost cuts

Editor's pick
Nature Medicine
7 August 2013
HIV treatment for children & young people

Efavirenz in children: WHO dosing guidelines raise the risk of side-effects in Thai children

News
9 July 2013
HIV treatment for children & young people

Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children

News
9 July 2013
Starting treatment

Reduced efavirenz dose suppresses HIV as well as standard dose

News
4 July 2013
Drug interactions & pharmacokinetics

Interaction between steroid injections and HIV protease inhibitors can disrupt cortisol levels

News
20 June 2013